You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IIIB

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)

Recruiting
  • Gastric Cancer Stage IIIB-IIIC
  • Pembrolizumab + SOX
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 7, 2023

Hyperkalemia Trial in Ranica (Veltassa Oral Powder Product, Placebo)

Not yet recruiting
  • Hyperkalemia
  • Veltassa Oral Powder Product
  • Placebo
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 29, 2023

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

Not yet recruiting
  • Non-small Cell Lung Cancer
  • NGS and ctDNA-MRD detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Hepatocellular Carcinoma Trial (Hepatectomy Combined With Camrelizumab and Apatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hepatectomy Combined With Camrelizumab and Apatinib
  • Nanning, China
    Guangxi Medical University Cancer Hospital
Sep 4, 2022

NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Jun 26, 2023

Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

Completed
Has Results
  • Unresectable Stage IIIB-IV Malignant Melanoma
  • Talimogene laherparepvec
  • Nagoya-shi, Aichi, Japan
  • +8 more
Jan 13, 2023

Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

Recruiting
  • Lung Squamous Cell Carcinoma
  • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
  • Yancheng, Jiangsu, China
    Yancheng Clinical College of Xuzhou Medical University
Mar 21, 2023

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Melanoma Trial in Wollstonecraft, Cairns (tigilanol tiglate)

Recruiting
  • Melanoma
  • tigilanol tiglate
  • Wollstonecraft, New South Wales, Australia
  • +2 more
Oct 6, 2022

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Melanoma Trial in Salt Lake City (Nivolumab, HF10)

    Terminated
    Has Results
    • Melanoma
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Jun 9, 2022

    Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

    Recruiting
    • Gastric Cancer, Adjuvant Chemotherapy, XO
    • Docetaxel and capecitabine and oxaliplatin
    • capecitabine and oxaliplatin
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 30, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

    Terminated
    • Metastatic Colon Adenocarcinoma
    • +27 more
    • San Francisco, California
    • +1 more
    Jan 5, 2023

    Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

    Terminated
    • Recurrent Melanoma
    • +3 more
    • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    • Laboratory Biomarker Analysis
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

    Active, not recruiting
    • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

    Not yet recruiting
    • Unresectable Lung Non-Small Cell Carcinoma
    • serplulimab plus chemotherapy as conversion treatment
    • (no location specified)
    Apr 27, 2023

    Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

    Active, not recruiting
    Has Results
    • Advanced Bile Duct Carcinoma
    • +17 more
    • Rochester, Minnesota
      Mayo Clinic
    Jan 5, 2023

    Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

    Active, not recruiting
    • Anatomic Stage IIB Breast Cancer AJCC v8
    • +19 more
    • Gilbert, Arizona
    • +4 more
    Dec 6, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Amsterdam, NH, Netherlands
      Antoni van Leeuwenhoek ziekenhuis
    Feb 11, 2022

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Stage IV Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer Trial (basic nutrition, oral supplement of

    Not yet recruiting
    • Stage IV Gastric Cancer
    • +4 more
    • basic nutrition
    • oral supplement of creatine and curcumin
    • (no location specified)
    May 16, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

    Active, not recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • Lymph Node Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Mar 15, 2022